News
21hon MSN
New 100-week data from the ongoing Phase I/II study of zigakibart, an investigational anti-APRIL monoclonal antibody, ...
Researchers at the Ragon Institute have made a significant discovery about how antibodies can directly enhance the body's ...
A Fargo veterinary clinic is reporting an outbreak of canine parvovirus. Prairie Winds Veterinary Center has confirmed cases ...
22h
News-Medical.Net on MSNNew data shows zigakibart sustains proteinuria remission and kidney function in IgA nephropathyNew 100-week data from the ongoing Phase 1/2 study of zigakibart, an investigational anti-APRIL monoclonal antibody, ...
Respiratory syncytial virus (RSV) causes millions of childhood illnesses yearly, particularly in poorer countries. On 30 May 2025, the World Health Organisation issued its first global guidance ...
3d
Clinical Trials Arena on MSNSanofi and Regeneron report results from two Phase III trials of COPD treatmentSanofi and Regeneron have reported that the Phase III AERIFY-1 trial of the fully human monoclonal antibody itepekimab.
The FDA has designated the viral vector rAAVrh74, which Sarepta Therapeutics, Inc. (NASDAQ:SRPT) uses in its gene therapy ...
Malappuram: Health Minister Veena George on Friday announced that the Nipah-infected patient from Valanchery has tested ...
The FDA has approved Nucala (mepolizumab) for the add-on maintenance treatment of patients with inadequately controlled eosinophilic COPD.
Breast cancer study results impressed at this year’s meeting, but raised new questions. Doctors also wrestled with how best ...
Learn about May 2025’s top biotech deals, featuring major collaborations in RNA interference technology, small molecules, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results